|
시장보고서
상품코드
1672703
위마비 치료 시장 : 약제 클래스별, 질환 적응증별, 유형별, 투여 경로별, 유통 채널별, 지역별Gastroparesis Treatment Market, By Drug Class, By Disease Indication, By Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
세계의 위마비 치료 시장은 2025년에는 83억 3,000만 달러로 추정되며, 2032년에는 115억 8,000만 달러에 달할 것으로 예측되며, 2025-2032년에 CAGR 4.8%로 성장할 것으로 예측됩니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 | 2024 | 2025년 시장 규모 | 83억 3,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 : 2025-2032년 CAGR : | 4.80% | 2032년 가치 예측 | 115억 8,000만 달러 |
세계 위부전마비 치료제 시장의 성장은 당뇨병과 특발성 위부전마비 유병률 증가가 주도하고 있습니다. 위부전 마비(위 배출 지연)는 위가 내용물을 비우는 데 시간이 너무 오래 걸리는 만성질환입니다. 위마비 환자는 식사 후 메스꺼움, 구토, 복부 팽만감, 포만감을 경험합니다. 현재 위부전마비를 완치할 수 있는 치료법은 없으며, 현재 사용 가능한 치료법은 증상 조절에 초점을 맞추었습니다. 신약 개발과 관련된 연구개발 활동이 증가함에 따라 시장 성장을 가속할 수 있습니다.
시장 역학:
세계 위부전마비 치료제 시장의 성장은 당뇨병 인구 증가, 특발성 위부전마비 유병률 증가, 위부전마비에 대한 국민과 의사의 인식 증가 등의 요인에 의해 이루어지고 있습니다. 그러나 경구용 약물에 따른 환자 순응도 저하, 효과적인 치료법의 부재, 약수처리의 부작용 등이 시장 성장을 저해하는 요인으로 작용할 수 있습니다. 더 나은 효능과 부작용이 적은 신약의 개발은 시장에 유리한 성장 기회를 제공할 수 있습니다.
본 조사의 주요 특징
세계의 위부전마비 치료제 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
또한 다양한 부문에 걸친 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 중요한 인사이트를 제공합니다.
이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개 변수를 기반으로 세계 위부전 마비 치료 시장의 주요 기업 개요을 제공합니다.
본 조사의 대상이 되는 주요 기업에는 Abbott Laboratories, Medtronic, Mylan, Pfizer, Johnson &Johnson Services, Bausch Health, Antrotrans, Alembic Pharmaceuticals 등이 포함됩니다.
이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
세계 위마비 치료 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 위마비 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사의 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 리포트 설명
- 시장의 정의와 범위
- 개요
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 주요 하이라이트
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER의 산업 분석
- 합병과 인수 시나리오
제4장 세계의 위마비 치료 시장, 약제 클래스별, 2020-2032년, (10억 달러)
- 소화관 운동 촉진제
- 항구토제
- 프로톤 펌프 저해제
- 기타(보툴리눔톡신(보톡스) 주사 등)
제5장 세계의 위마비 치료 시장, 질환 적응증별, 2020-2032년, (10억 달러)
- 당뇨병성 위마비
- 특발성 위마비
- 수술후 위마비
제6장 세계의 위마비 치료 시장, 유형별, 2020-2032년, (10억 달러)
- OTC 의약품
- 처방약
제7장 세계의 위마비 치료 시장, 투여 경로별, 2020-2032년, (10억 달러)
- 경구
- 주사제
- 비강
제8장 세계의 위마비 치료 시장, 유통 채널별, 2020-2032년, (10억 달러)
- 병원 약국
- 소매 약국
- 온라인 약국
제9장 세계의 위마비 치료 시장, 지역별, 2020-2032년(10억 달러)
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동
- 아프리카
제10장 경쟁 구도
- Evoke Pharma, Inc.
- Processa Pharmaceuticals, Inc.
- Neurogastrx, Inc.
- Vanda Pharmaceuticals Inc.
- ANI Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi S.A.
제11장 애널리스트의 권장사항
제12장 참고 문헌과 조사 방법
- 참고 문헌
- 조사 방법
- 출판사 소개
Global Gastroparesis Treatment Market is estimated to be valued at USD 8.33 Bn in 2025 and is expected to reach USD 11.58 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 8.33 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.80% | 2032 Value Projection: | USD 11.58 Bn |
Global gastroparesis treatment market growth is driven by rising prevalence of diabetes and idiopathic gastroparesis. Gastroparesis, or delayed stomach emptying, is a chronic disorder, in which the stomach takes too long to empty its contents. Patients suffering from gastroparesis experience nausea, vomiting, bloating and fullness after eating. Currently, there is no cure for gastroparesis and the available treatment options focus on managing the symptoms. Rising research and development activities related to new drug development can drive the market growth.
Market Dynamics:
Global gastroparesis treatment market growth is driven by factors such as increasing diabetic population, rising prevalence of idiopathic gastroparesis, growing awareness about gastroparesis among people and physicians. However, poor patient compliance associated with oral medication, non-availability of effective treatment and side effects of drug therapies can hamper the market growth. Development of novel drugs with better efficacy and less side effects can offer lucrative growth opportunities in the market.
Key features of the study:
This report provides in-depth analysis of the global gastroparesis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gastroparesis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Medtronic, Mylan, Pfizer, Johnson & Johnson Services, Bausch Health, Antrotrans, Alembic Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global gastroparesis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gastroparesis treatment market
Detailed Segmentation-
- Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Prokinetic Agents
- Antiemetic Drugs
- Proton Pump Inhibitors
- Others (Botulinum Toxin Injections, etc.)
- Disease Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Diabetes Gastroparesis
- Idiopathic Gastroparesis
- Post-surgical Gastroparesis
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Over-the-Counter Drugs
- Prescription Drugs
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Injectables
- Nasal
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Evoke Pharma, Inc.
- Processa Pharmaceuticals, Inc.
- Neurogastrx, Inc.
- Vanda Pharmaceuticals Inc.
- ANI Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Gastroparesis Treatment Market, By Drug Class
- Global Gastroparesis Treatment Market, By Disease Indication
- Global Gastroparesis Treatment Market, By Type
- Global Gastroparesis Treatment Market, By Route of Administration
- Global Gastroparesis Treatment Market, By Distribution Channel
- Global Gastroparesis Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Gastroparesis Treatment Market, By Drug Class, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Prokinetic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antiemetic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Proton Pump Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Botulinum Toxin Injections, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Gastroparesis Treatment Market, By Disease Indication, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Diabetes Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Idiopathic Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Post-surgical Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Gastroparesis Treatment Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Over-the-Counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Gastroparesis Treatment Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Gastroparesis Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Gastroparesis Treatment Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021- 2032, e (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country/Sub-region, 2020 - 2032, (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Evoke Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Processa Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neurogastrx, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vanda Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ANI Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi S.A.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
